Should Drug Companies Engage with ICER? An Empirical Analysis of How Often Manufacturers Engage with ICER and Whether Engagement May Influence ICER’s Cost-Effectiveness Estimates

Detalles Bibliográficos
Autores principales: Breslau, Rachel Milstein, Cohen, Joshua T., Ollendorf, Daniel A., Neumann, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596652/
https://www.ncbi.nlm.nih.gov/pubmed/35871128
http://dx.doi.org/10.1007/s41669-022-00358-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596652/
https://www.ncbi.nlm.nih.gov/pubmed/35871128
http://dx.doi.org/10.1007/s41669-022-00358-y

Ejemplares similares